Angiotensin-Neprilysin Inhibition in Heart Failure with Pre-served Ejection Fraction Scott D. Solomon, John J.V. McMurray, Inder S. Anand, Junbo Ge, Carolyn S.P. Lam, Aldo P. Maggioni, Felipe Martinez, Milton Packer, Marc A. Pfeffer, Burkert Pieske, Margaret M. Redfield, Jean L. Rouleau et al., for the PARAGON-HF Investigators and Committees (in N Engl J Med 2019;381:1609-1620—DOI:10.1056/NEJMoa1908655).
Interviewed: Rui Baptista
Interviewer: Ricardo Fontes-Carvalho
Link: https://www.youtube.com/watch?v=dUeicbG21-c&feature=youtu.be
Conflicts of interestThe authors declare to have received fees for lectures and invitations to attend scientific congresses from Novartis and Servier, companies that co-promote sacubitril-valsartan.
Please cite this article as: Breve comentário vídeo ao Artigo Recomendado do Mês. Rev Port Cardiol. 2020. https://doi.org/10.1016/j.repc.2020.03.011
